ClinicalTrials.gg
RecruitingNCT05829161Updated Feb 27, 2026

Sensory Phenotypes of Autism Spectrum Disorder

An observational study in Autism, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by National Taiwan University Hospital · Observational

How we know

From the registry’s dates

  • Started Jan 2020; still recruiting 6 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
480
Ages
18 Months and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Autistic Disorder by National Taiwan University Hospital — 6 open to participants now, 6 under way, none of them phase 3. Autistic Disorder · National Taiwan University Hospital.

Started
2020
with 1 other
Observational
6 of 12
3 open now
Registered
4th of 12
by date

Among the 12 studies in Autistic Disorder by National Taiwan University Hospital, this one is one of 2 that started in 2020, is one of 6 observational ones, and was the 4th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

6 of the 12 studies in Autistic Disorder by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 18 Months and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Autistic Disorder by National Taiwan University Hospital, or all of them as a file.
02

Study summary

This project plans to establish sensory phenotypes of a Taiwanese ASD cohort across lifespan, including variety of sensory modalities, sensory domains, and clinical correlates.

Also, we will clarify the relationship between sensory phenotypes and social impairment by two specific sensory-social paradigms targeting eye gaze avoidance and social touch anxiety, as well as the atypical neural representation of ASD during eye gaze and viewing social touch by fMRI and EEG.

Read the detailed description

Sensory disturbance of autism spectrum disorder (ASD) are life-long highly-impairing challenges for the individual. Anxiety and fear around the sensory issues significantly threatens the psychological and mental health. As a newly introduced diagnostic criteria of ASD, sensory characteristics becomes a recent focus of ASD research. The ASD population is aging, how their sensory features naturally change with age is particular relevant for their adaptation. However, current literature are limited to childhood and young adults and mostly rely on behavioral report, lacking a clear whole picture of changing sensory phenotype in terms of different sensory modality and sensory domains. Besides, how sensory characteristics in ASD can be quantified by objective measures or explored by qualitative approach, how the sensory sensitivity contributes to the core social deficits in ASD such as eye gaze or social touch avoidance are unclear. This project plans to achieve the following aims:

  1. Establish sensory phenotypes of a Taiwanese ASD cohort across lifespan, including variety of sensory modalities (i.e., visual, tactile, auditory, smell/taste, proprioception, etc.), sensory domains (i.e., low registration, sensory seeking, sensory sensitivity, and sensory avoiding), and clinical correlates.
  2. Clarify the relationship between sensory phenotypes and social impairment by two specific sensory-social paradigms targeting eye gaze avoidance and social touch anxiety, which are hallmarks of ASD. Factors of emotion types as well as familiarity of faces or social/object touch will be manipulated to examine how they moderate eye tracking and pupil response.
  3. Identify the atypical neural representation of ASD during eye gaze and viewing social touch by fMRI and EEG.
03

Conditions studied

  • Autism

Browse trials for

04

Who can participate

Ages eligible
18 Months and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants with autism spectrum disorder, recruited from National Taiwan University Hospital

Eligibility criteria

Aim#1

Inclusion Criteria:

  • Diagnosis of autism spectrum disorder Aim#2 and #3

ASD group:

Inclusion Criteria:

  • Diagnosis of autism spectrum disorder
  • Age above 12-40 years old

Exclusion Criteria:

  • No diagnosis of autism spectrum disorder
  • Pregnant woman
  • Metal implant in the body

TD group:

Inclusion Criteria:

  • No diagnosis of autism spectrum disorder
  • Age above 12-40 years old

Exclusion Criteria:

  • History of major psychiatric disorders
  • Pregnant woman
  • Metal implant in the body
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
480 participants (estimated)
Patient registry
No

Groups and cohorts

  • ASD Group

    ASD participants, no intervention

    Behavioral: no intervention

  • TD Group

    TD participants, no intervention

    Behavioral: no intervention

Interventions

  • Behavioralno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Sensory Profile

    It is a self-report scale covers 6 sensory modalities, including taste/smell, motion, visual, tactile, activity, and auditory sensation. The scoring method was based on 4-dimension structure, i.e. Low Registration, Sensation Seeking, Sensory Sensitivity, and Sensation Avoiding. Higher scores mean worse symptoms for each dimension compared to average healthy controls

    Time frame: 2 years

Secondary outcomes

  1. Brain activation through fMRI data

    MRI scanning session consist of eye-avoidance paradign, social touch paradigm and anatomical scan. Regions of interest for eye avoidance paradigm included brain regions that have been shown to involve face-to-face social and emotional interaction. ROIs for social touch paradigm select the areas that are known to mediate the processing of visually presented social touch scenes.

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for Dec 2028, 107 months after the start.

Of 57 non-industry observational studies under Autistic Disorder, half reached primary completion within 72 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 144. This study's planned 107 months is above that.

Counting every sponsor, half of 65 studies reached it within 43 months; a quarter within 20 and three quarters within 120.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2019
First posted
Apr 25, 2023
StartActual
Jan 1, 2020
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2028
Last update
Feb 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05829161
Responsible party
Sponsor
First posted
Apr 25, 2023
Start date
Jan 1, 2020
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Feb 27, 2026

Study contacts

Yi Ling Chien
Contact
ylchien@hotmail.com
886-2-2312-3456 ext. 66013
Yi Ling Chien
principal investigator · National Taiwan University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion